BDX vs CCEL · P/E 34, rev $21.84B vs P/E 490, $39.6M cap
Becton Dickinson and Company (BDX) versus CryoCell International Inc (CCEL) — a side-by-side from cached financials, not a winner call.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
CCEL does not have a complete income-statement cache yet.
BDX currently screens at market cap $50.30B and trailing P/E 33.9. CCEL currently screens at market cap $39.6M and trailing P/E 490.0.
Not investment advice. Open the BDX and CCEL stock pages for the full models.
Not investment advice.